CLYM Climb Bio, Inc: Net earnings per share for the last 12 months

Public company logo of Climb Bio Inc. (CLYM)

Climb Bio Inc (CLYM) maintains a high level of authority in the therapy of rare immune disorders, earning expert recognition for its developments. The team consists of leading biologists creating innovative treatment methods in high-tech laboratories. The price history of the shares on GURU.Markets shows an EPS (TTM) of -9.50. However, the company's success depends on early trial results and patent protection, which creates significant risks.

CLYM Climb Bio Inc. Earnings per share for the last twelve months (11/23/2025 - 11/13/2026)

Climb Bio, Inc. - analytical breakdowns and key metrics (CLYM)

- market value and analyst target forecast:
Stock Quotes climbbio.com|CLYM - Price Target Chart
- company stock capitalization data:
Market Valuation Climb Bio, Inc.|CLYM - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share Climb Bio|CLYM - Company Book Value|Capitalization to Book Value Ratio climbbio.com|CLYM - Company Total Assets
- debt burden and liquidity indicators:
Debt to Capital Climb Bio Inc|CLYM - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Climb Bio, Inc|CLYM - Company Debts|Debt to Book Capitalization Ratio Climb Bio, Inc.|CLYM - Company Long-Term Debts|Short-Term Debt Volume Climb Bio|Quick Liquidity Indicator climbbio.com
- earnings and multiples data:
CLYM - Net Profit|Expected Profit Climb Bio Inc|CLYM - Price to Earnings Ratio|Future Price to Earnings Multiple Climb Bio Inc.|CLYM - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Climb Bio, Inc.|CLYM - Operating profit EBITDA|Net earnings per share for the last four quarters Climb Bio|CLYM - Earnings per share for the last twelve months|Earnings per share growth in annualized terms for the last twelve months climbbio.com|CLYM - Net earnings per share growth this year|Expected earnings per share trend next year Climb Bio Inc
Initial company analysis:climbbio.com - CLYM
Core merchandise of Climb Bio Inc

Climb Bio Inc (CLYM) focuses on immunotherapy for autoimmune diseases, which creates binary risks due to the absence of commercial products. By analyzing the YoY EPS volatility over the last 12 months, an investor can observe profit dynamics stripped of one-time write-offs. This metric compares adjusted data against strict GAAP standards to identify real financial progress. Ignoring this gap amidst inflated expectations significantly reduces capital resilience.

Competitor analysis for Climb Bio Inc

argenx.com (ARGX) - Net earnings per share for the last 12 months|BioNTech (BNTX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Abivax Corp|Net earnings per share for the last 12 months ADMA|Net earnings per share (EPS TTM) Protagonist Corp|Earnings per share for the last twelve months Immunovant, Inc. (IMVT)|kiniksa.com - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) GRFS (Grifols)|Adaptive Biotech (ADPT) - Net earnings per one share for the last twelve months|Celldex - Net earnings per share (EPS TTM)|Aurinia Corp (AUPH) - Net earnings per share for the last 12 months|BioCryst (BCRX) - Earnings per share for the last twelve months|VERA (veratx.com) - Earnings per share for the last twelve months|DNTH (Dianthus Therapeutics, Inc.) - Net earnings per share (EPS TTM)|Pharvaris NV (PHVS) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months AbCellera Corp (ABCL)|Net earnings per share for the last 12 months Tourmaline TRML|Net earnings per share (EPS TTM) PGEN (Precigen, Inc.)|pharming.com - Earnings per share for the last twelve months|NKTR: Net earnings per share for the last 12 months|Earnings per share for the trailing year UPB (Upstream Bio, Inc.)|ZBIO: Net earnings per share (EPS TTM)|IMNM (Immunome Bio) - Earnings per share for the last twelve months|GOSS (Gossamer Bio, Inc.) - Net earnings per share (EPS TTM)|kalvista.com (KALV) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Septerna (SEPN)|PVLA - Net earnings per one share for the last twelve months|Savara Corp - Net earnings per share for the last 12 months|Earnings per share for the trailing year RIGL|AnaptysBio, Inc. - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters astriatx.com ATXS|enGene (ENGN) - Earnings per share for the last twelve months|Earnings per share for the last 12 months RAPT|JBIO (Aerovate Therapeutics, Inc.) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Aclaris Therapeutics, Inc (ACRS)|Net earnings per share (EPS TTM) KYTX|Net earnings per share for the last 12 months tizianalifesciences.com TLSA|Earnings per share for the last twelve months Cabaletta Bio CABA|Ventyx Biosciences Inc. - Earnings per share for the last twelve months|THTX: Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months Avalo Therapeutics Inc|Eledon Pharmaceuticals (ELDN) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months agenusbio.com|Earnings per share for the last twelve months Zura Bio Limited|aTyr Pharma Inc - Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) ADAG|IMA (ikenaoncology.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) STTK (Shattuck Labs)|Net earnings per share (EPS TTM) Equillium Inc EQ|CNTB - Earnings per share for the last twelve months|Earnings per share for the trailing year IMUX (Immunic, Inc.)|atarabio.com (ATRA) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months InflaRx|XFOR (X4 Pharmaceuticals) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Adicet|Net earnings per share for the last 12 months CELU (Celularity Inc.)|INMB (INmune Bio Inc) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) BRNS (Barinthus Bio)|Net earnings per share for the last four quarters Kezar Life Sciences Inc (KZR)|SABS - Earnings per share for the last twelve months|akaritx.com (AKTX) - Net earnings per share for the last 12 months|enlivex.com (ENLV) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Q32 Bio|Net earnings per share for the last 12 months GOVX|Net earnings per share (EPS TTM) Edesa Biotech Corp|Earnings per share for the last twelve months iBio, Inc. (IBIO)|carismatx.com - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) XTLB (XTL Biopharmaceuticals Ltd.)|Bolt Biotherapeutics Inc. (BOLT) - Net earnings per one share for the last twelve months|HCW Biologics Inc - Net earnings per share (EPS TTM)|Aptevo Therapeutics (APVO) - Net earnings per share for the last 12 months|AIM ImmunoTech (AIM) - Earnings per share for the last twelve months|ADTX (Aditxt, Inc.) - Earnings per share for the last twelve months|GRI (GRI Bio) - Net earnings per share (EPS TTM)|XORTX Therapeutics Inc (XRTX) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months ReShape Lifesciences (HIND)|Net earnings per share for the last 12 months Revelation Biosciences Corp REVB|Net earnings per share (EPS TTM) INDP (Indaptus Therapeutics)|scinai.com - Earnings per share for the last twelve months|CALI: Net earnings per share for the last 12 months|Earnings per share for the trailing year AFMD (Affimed)|ALLK: Net earnings per share (EPS TTM)|HOOK (HOOKIPA Pharma) - Earnings per share for the last twelve months|IGMS (IGM Biosciences Inc.) - Net earnings per share (EPS TTM)|iteostherapeutics.com (ITOS) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Ocean Biomedical (OCEA)|TCBP - Net earnings per one share for the last twelve months|Third Harmonic Bio, Inc - Net earnings per share for the last 12 months